Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,261,197 papers from all fields of science
Search
Sign In
Create Free Account
S 0139
Known as:
S-0139
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Broader (3)
Caffeic Acids
Endothelin receptor antagonist
Oleanolic Acid
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Synergistic Effect of an Endothelin Type A Receptor Antagonist, S-0139, With rtPA on the Neuroprotection After Embolic Stroke
R. Zhang
,
Chunling Zhang
,
+9 authors
M. Chopp
Stroke
2008
Corpus ID: 1096456
Background and Purpose— Using a model of embolic stroke, the present study tested the hypothesis that blockage of endothelin-1…
Expand
2003
2003
Highly enhanced permeability of blood-brain barrier induced by repeated administration of endothelin-1 in dogs and rats.
Itaru Narushima
,
T. Kita
,
+5 authors
T. Nakashima
Acta Pharmacologica et Toxicologica
2003
Corpus ID: 12735604
The effects of intracisternal administration of endothelin-1 on blood-brain barrier permeability were examined in dogs and rats…
Expand
Review
2002
Review
2002
S-0139 (Shionogi).
J. R. Wu-Wong
Current opinion in investigational drugs
2002
Corpus ID: 26027684
Shionogi and GlaxoSmithKline (GSK), as the joint venture company Shionogi-GlaxoSmithKline Pharmaceuticals LLC, are developing S…
Expand
Highly Cited
2001
Highly Cited
2001
Protective Effect of Endothelin Type A Receptor Antagonist on Brain Edema and Injury After Transient Middle Cerebral Artery Occlusion in Rats
Y. Matsuo
,
S. Mihara
,
M. Ninomiya
,
M. Fujimoto
Stroke
2001
Corpus ID: 12079777
Background and Purpose— Recent evidence strongly suggests that endothelins (ETs) play an important role in the regulation of…
Expand
2000
2000
Endothelin receptor subtype antagonist activity of S-0139 in various isolated rabbit and canine arteries.
T. Iwasaki
,
Y. Hayasaki‐Kajiwara
,
T. Shimamura
,
N. Naya
,
M. Nakajima
European Journal of Pharmacology
2000
Corpus ID: 35073244
1999
1999
Different roles of two types of endothelin receptors in partial ablation-induced chronic renal failure in rats.
T. Shimizu
,
S. Hata
,
T. Kuroda
,
S. Mihara
,
M. Fujimoto
European Journal of Pharmacology
1999
Corpus ID: 10531161
1999
1999
Contribution of endothelin-1 to disruption of blood-brain barrier permeability in dogs
Itaru Narushima
,
T. Kita
,
+5 authors
Toshikatsu Nakashima
Naunyn-Schmiedeberg's Archives of Pharmacology
1999
Corpus ID: 26007261
Abstract. We examined the effect of intracisternal application of endothelin-1 (ET-1) on the permeability of fluorescein into the…
Expand
1999
1999
A preventive effect of a selective endothelin-A receptor antagonist, S-0139, on the erythropoietin-induced reduction of the renal cortical blood flow
A. Ishikawa
,
Kazuo Suzuki
,
K. Fujita
Urological research
1999
Corpus ID: 25096816
Abstract We have confirmed that renal cortical blood flow (RCBF) is significantly decreased by recombinant human erythropoietin…
Expand
1998
1998
Potential contribution of endothelin to renal abnormalities in glycerol-induced acute renal failure in rats.
T. Shimizu
,
T. Kuroda
,
M. Ikeda
,
S. Hata
,
M. Fujimoto
Journal of Pharmacology and Experimental…
1998
Corpus ID: 8361502
We studied the possible participation of endothelin-1 (ET-1) in the pathogenesis of renal damage in glycerol-induced acute renal…
Expand
Highly Cited
1996
Highly Cited
1996
ICAM-1 expression on cardiac myocytes and aortic endothelial cells via their specific endothelin receptor subtype.
Y. Hayasaki
,
Masatoshi Nakajima
,
Y. Kitano
,
Takanori Iwasaki
,
T. Shimamura
,
Kazumi Iwaki
Biochemical and Biophysical Research…
1996
Corpus ID: 42309555
Endothelin-1 (ET-1) and Endothelin-3 (ET-3) increased the expression of intercellular adhesion molecule-1 (ICAM-1) on rat…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE